1[1]Brophy JM,Bogaty P.Primary Angioplasty and Thrombolysis Are Both Reasonable Options in Acute Myocardial Infarction.Ann Intern Med,2004,141:292-297
2[2]A comparison of reteplase with alteplase for acute myocardial infarction.The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO Ⅲ) Investigators.N Engl J Med,1997,337:1118-1123
3[3]Topol E J,Ohman EM,Armstrong PW,et al.Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction:results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) Ⅲ Trial.Circulation,2000,102:1761-1765
4[4]Kurihara H,Matsumoto S,Tamura R,et al.Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.Am Heart J,2004,147 (4):E14
5[5]Inoue T,Nishiki R,Kageyama M,et al.Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction.Am J Cardiol,2005,95 (4):506-508
6[6]Cohen M,Arjomand H,Pollack CV Jr.The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction.Am J Emerg Med,2004,22:14-23
7[7]Iamach J.Thrombolytic bolus may give acute MI a thombolytic ride.Physical's Weekly,1999,16 (15):122
8[8]Sinnaeve P,Alexander J,Belmans A,et al.One-year follow-up of the ASSENT-2 trial:a double-blind,randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16 949 patients with ST-elevation acute myocardial infarction.Am Heart J,2003,146:27-32
9[9]InTIME-Ⅱ Investigators.Intravenous nPA for the treatment of infarcting myocardium early:InTIME-Ⅱ,a double blind comparison of single bolus lanoteplase vs.accelerated alteplase for the treatment of patients with acute myocardial infarction.Eur Heart J,2000,21:2005-2013
10[10]Al-Shwafi KA,de Meester A,Pirenne B,Col JJ.Comparative fibrinolytic activity of front-loaded alteplase and the singlebolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarction.Am Heart J,2003,145 (2):217-225
6Durante W, Liao L, Schafer A I. Differential regulation of L-arginine transport and inducible NOS in culture vascular smooth muscle cells. Am J Physiol, 1995,268:H1158～H1164
7Rote W E, Davis J H, Morsa S A, et al. Antithrombotic effects of DMP 728, a platelet GPⅡb/Ⅲa a receptor antagonist, in a canine model of arterial thrombosis. J Cardiovasc Pharmacol, 1994,23:681～689
8Kurz K D, Main B W, Sandusky G E. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res, 1990,60(4):269～280
9Nguyen P D, O'Rear E A, Johnson A E, et al. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circ Res, 1990,66(3):875～878
